In a fiercely competitive fast-food landscape, Domino's Pizza is navigating the challenge of sustaining its growth trajectory. The company's strategy hinges on ...
Wall Street's attention has turned to biotech firm Ocugen as it advances its gene therapy programs for inherited retinal diseases. While clinical development pr ...